Navigation Links
Vasogen Announces First Quarter 2009 Results
Date:4/13/2009

--------------------------------------------------------------------- Period from December 1, Three months ended 1987 to February 28, February 29, February 28, 2009 2008 2009 ------------------------------------------------------------------------- Expenses: Research and development $ 36 $ 2,778 $ 247,747 General and administration 2,446 2,681 127,772 Foreign exchange loss (gain) (30) 203 10,635 ------------------------------------------------------------------------- Loss before the undernoted (2,452) (5,662) (386,154) Interest expense on senior convertible notes payable - - (1,279) Accretion in carrying value of senior convertible notes payable - - (10,294) Amortization of deferred financing costs - - (3,057) Loss on extinguishment of senior convertible notes payable - - (6,749) Gain on sale of patents 487 - 487 Investment income 24 342 13,862 Change in fair value of embedded derivatives - - 829 ------------------------------------------------------------------------- Loss and comprehensive loss for the period (1,941) (5,320) (392,355) Deficit, beginning of period (397,857) (381,783) (1,510) Impact
'/>"/>
SOURCE Vasogen Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vasogen Announces 2008 Year-End Results
2. Vasogen Announces Sale of Patent Application and Provides Corporate Update
3. Vasogen Complies with NASDAQ Marketplace Rule 4350(c)(1)
4. Vasogen Provides Corporate Update
5. Vasogen Announces Third Quarter 2008 Results
6. Vasogen Announces Second Quarter 2008 Results
7. Vasogen Provides Corporate Update
8. Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference
9. Vasogen Receives NASDAQ Notification Related to Minimum Bid Price
10. Vasogen Announces Implementation of Strategic Restructuring Plan
11. Vasogen Announces First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Chantel Lee ’15 and Eli Capello ’15 sacrificed ... with Dr. Juan Rodriguez, Professor of Physics, in an effort ... eye disease caused by changes in the blood vessels of ... is quite remarkable,” said Rodriguez. “They took on a graduate ... and together carried it to near completion in just a ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Applied ... provider of DNA-based anti-counterfeiting technology and product authentication solutions, ... 2014 to discuss its fiscal third quarter results. The ... the SEC by the end of the day on ... Inc. management will host a conference call beginning at ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 This is ... of the Ammonium Bicarbonate industry in Global and China. ... including definitions, applications and industry chain structure. Global market ... a focus on history, developments, trends and competitive landscape ... Chinese situation is also offered. , The report also ...
(Date:8/1/2014)... Aug. 1, 2014 Research and ... "The World Market for Flow Cytometry in IVD ... http://photos.prnewswire.com/prnh/20130307/600769 Flow ... now an important component of advanced IVD labs ... for cancer diagnostics, but their newer clinical applications ...
Breaking Biology Technology:Two Centenary College Students Tackle Diabetic Retinopathy Research 2Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014 2Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014 3Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 2Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 3The World Market for Flow Cytometry in IVD Applications 2
... Nile Therapeutics,Inc. (OTC Bulletin Board: NILT.OB), a ... today announced the,appointment of Gregory W. Schafer to ... audit committee. Mr. Schafer is a seasoned biotechnology ... finance and operations., "We are delighted to ...
... Lentigen Corporation today announced,the appointment of Tim Ravenscroft ... chairman, commented, "The board of Lentigen,is delighted that ... are about to enter,clinical trials for our first ... particularly strong background and global leadership in,healthcare products ...
... Arno Therapeutics, Inc., a,privately held drug development ... license agreements with The Ohio State University,("OSU") for ... therapies for cancer., Pursuant to the license ... for the treatment of cancer, including OSU-03012 (NSC,D728209) ...
Cached Biology Technology:Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors 2Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors 3Lentigen Appoints Tim Ravenscroft as Chief Executive Officer 2Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds 2Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds 3
(Date:8/1/2014)... a quantum state collapses from a quantum superposition to a ... path known as a quantum trajectory. For each start and ... but it is not as easy to predict the path ... would be in our everyday, classical world. , In a ... Nature , scientists from the Institute for Quantum Studies at ...
(Date:8/1/2014)... More than 10,000 reptile species have been recorded ... all living reptile species and classification, making the ... in the world, alongside bird and fish species. ... 2014 would mark the year that reptiles would ... world. Reptiles include snakes, lizards, turtles, crocodiles, tuataras ...
(Date:8/1/2014)... fossil record about 200,000 years ago, but it was ... advanced tools became widespread. , A new study ... finds that human skulls changed in ways that ... same time that culture was blossoming. , "The modern ... cultural exchange probably came at the same time that ...
Breaking Biology News(10 mins):Mapping the optimal route between two quantum states 2Reptile Database surpasses 10,000 reptile species 2Reptile Database surpasses 10,000 reptile species 3Society bloomed with gentler personalities and more feminine faces 2
... Colorado and TUSTIN, Calif., April 21, 2009--Peregrine ... biopharmaceutical company developing monoclonal antibodies for the ... today reported that two preclinical studies presented ... provided further confirmation of the immunomodulatory mechanisms ...
... 50 years as one of the most effective treatments ... been entirely sure exactly how it operates in the ... scientists suggests a mechanism for how Lithium works, opening ... tests on cells have shown that Lithium affects a ...
... MEDFORD/SOMERVILLE, Mass. -- A collaborative team of student designers, ... and Tufts University will use Earth Day as an ... a house that will be solar powered, attractive and ... April 22, at 11:00 a.m. at Sophia Gordon Hall ...
Cached Biology News:Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies 2Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies 3Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies 4Tufts students host Earth Day with groundbreaking ceremony for solar house 2Tufts students host Earth Day with groundbreaking ceremony for solar house 3
... The Brownlee Precision Model 440 incorporates ... circuitry in a friendly easy-to-use instrument. Each ... amplifier, an 8-pole Bessel lowpass filter, a ... output offset controls. A control knob sets ...
... versatile & modular instrument which can be used ... Extracellular, Transducer & Multi-channel Isolated Amplification ... Supply unit (NL900D) forms the heart of every ... by this unit, but wiring within the case ...
Rat Epidermal Keratinocytes (REK) (>500,000 cells)...
... The Brownlee Precision Model 410 is a ... used to amplify small signals from sources which ... frequency noise. Each channel consists of a high ... 2-pole lowpass filter, and an output offset control. ...
Biology Products: